Alcon Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALCON LABS INC, and when can generic versions of ALCON LABS INC drugs launch?
ALCON LABS INC has seventeen approved drugs.
There are forty US patents protecting ALCON LABS INC drugs.
There are two hundred and seventeen patent family members on ALCON LABS INC drugs in thirty-one countries and twenty-eight supplementary protection certificates in ten countries.
Summary for Alcon Labs Inc
International Patents: | 217 |
US Patents: | 40 |
Tradenames: | 14 |
Ingredients: | 12 |
NDAs: | 17 |
Drugs and US Patents for Alcon Labs Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon Labs Inc | LEVOBUNOLOL HYDROCHLORIDE | levobunolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 074851-001 | Oct 28, 1996 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Alcon Labs Inc | MYDRIACYL | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 084306-001 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
Alcon Labs Inc | ISOPTO ATROPINE | atropine sulfate | SOLUTION/DROPS;OPHTHALMIC | 208151-001 | Dec 1, 2016 | AT2 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
Alcon Labs Inc | EYSUVIS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210933-001 | Oct 26, 2020 | RX | Yes | Yes | 9,056,057 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Alcon Labs Inc | CYCLOMYDRIL | cyclopentolate hydrochloride; phenylephrine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 084300-001 | Approved Prior to Jan 1, 1982 | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alcon Labs Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alcon Labs Inc | PATADAY TWICE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 020688-001 | Dec 18, 1996 | 5,116,863*PED | ⤷ Subscribe |
Alcon Labs Inc | PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021545-001 | Dec 22, 2004 | 5,116,863*PED | ⤷ Subscribe |
Alcon Labs Inc | PATADAY TWICE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 020688-001 | Dec 18, 1996 | 5,641,805*PED | ⤷ Subscribe |
Alcon Labs Inc | SIMBRINZA | brimonidine tartrate; brinzolamide | SUSPENSION/DROPS;OPHTHALMIC | 204251-001 | Apr 19, 2013 | 6,316,441 | ⤷ Subscribe |
Alcon Labs Inc | PATADAY TWICE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 020688-001 | Dec 18, 1996 | 4,923,892 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Alcon Labs Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 2442790 | ⤷ Subscribe |
Poland | 3045164 | ⤷ Subscribe |
New Zealand | 700875 | ⤷ Subscribe |
European Patent Office | 2722035 | ⤷ Subscribe |
European Patent Office | 2844295 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Alcon Labs Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1631293 | 2014C/042 | Belgium | ⤷ Subscribe | PRODUCT NAME: MIRVASO (BRIMONIDINE) EN FARMACEUTISCHE ZOUTEN DAARVAN VOOR GEBRUIK ALS MEDICIJN VOOR HET BEHANDELEN VAN ROSACEA GEINDUCEERDE ROODHEID; AUTHORISATION NUMBER AND DATE: EU/1/13/904 20140221 |
3053913 | 301038 | Netherlands | ⤷ Subscribe | PRODUCT NAME: NETARSUDIL, OF EEN ZOUT OF SOLVAAAT DAARVAN, IN HET BIJZONDER NETARSUDILMESYLAAT; REGISTRATION NO/DATE: EU/1/19/1400 20191121 |
1631293 | 14C0056 | France | ⤷ Subscribe | PRODUCT NAME: BRIMONIDINE OU L'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/13/904 20140225 |
1631293 | 300683 | Netherlands | ⤷ Subscribe | PRODUCT NAME: BRIMONIDINE EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN VOOR TOEPASSING ALS GENEESMIDDEL VOOR DE BEHANDELING VAN DOOR ROSACEA GEINDUCEERDE ROODHEID; REGISTRATION NO/DATE: EU/1/13/904 20140225 |
3053913 | 122020000016 | Germany | ⤷ Subscribe | PRODUCT NAME: NETARSUDIL, ODER EIN ENANTIOMER, DIASTEREOMER, SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/19/1400 20191119 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.